Number Т. 9, № 3 (35) 2019

Brentuхіmab vedotin in the treatment of Hodgkin’s lymphoma

Kriachok I.A., Tytorenko I.

Summary. Brentuximab vedotin has been established as a highly effective drug that is included in the main treatment protocols of Hodgkin’s lymphoma. This article presents a list of studies that demonstrate the effectiveness of brentuximab vedotin both in monotherapy and in combination with different drugs for patients with relapsed/refractory Hodgkin’s lymphoma.
No Comments » Add your
Leave a comment